KeyOps, a Toronto-based Insights-as-a-Service (IaaS) startup, raised $4 million (CAD) in a seed funding round led by Graphite Ventures, with participation from MaRS IAF, StarForge, an Archangel Network fund, and the Velocity Fund.
A group of experienced SaaS experts and CEOs, including Carol Leaman (CEO of Axonify), James Novak (ex-CEO of Fiix Software), Danny Ardellini (CEO of Environmental 360 Solutions), and a network of physicians from HaloHealth, also participated in this round.
The Funding will be used to grow the team to aggressively expand U.S. market reach while growing its physician network across North America.
KeyOps plans to use its funding to add engineering, product development, and sales and marketing roles in the next year, focusing on its U.S. commercial team build-out.
The digital platform connects doctors and other key opinion leaders (KOL) to life science companies to enable faster commercial decision-making and better responses to patients' needs.
KeyOps currently works with device manufacturers, laboratory testing companies, and pharmaceutical customers across therapeutic areas.
Company: KeyOps
Raised: $4.0M
Round: Seed Round
Funding Month: December 2022
Lead Investors: Graphite Ventures
Additional Investors: MaRS IAF, StarForge, MaRS IAF, StarForge, Archangel Network fund, Velocity Fund, Carol Leaman, James Novak, and Danny Ardellini
Company Website: https://www.keyops.io/
Software Category: Insights and Engagement platform
About the Company: KeyOps is an insight and engagement platform that breaks down the communication barriers between life science companies and healthcare providers to enable better, real-time decision-making for medical affairs, marketing, and sales teams. Through a trusted and compliant digital platform, customers can build and manage on-demand relationships with a diverse, influential community of key opinion leaders and medical experts.
Source: https://www.newswire.ca/news-releases/keyops-raises-4-million-to-lead-the-digital-transformation-of-pharma-physician-engagement-892830890.html